Postdoctoral Scholar – Microbial Pathogenesis Tan and Suetterlin Lab
Open date: January 24, 2023
Most recent review date: Friday, Feb 24, 2023 at 11:59pm (Pacific Time)
Applications received after this date will be reviewed by the search committee if the position has not yet been filled.
Final date: Friday, Jun 30, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
Post-doctoral scholar positions (Ph.D.) funded by NIH are available immediately to study Chlamydia, the most commonly reported cause of infectious disease in the U.S. These projects are a collaboration between Dr. Christine Suetterlin (Department of Developmental and Cell Biology) and Dr. Ming Tan (Department of Microbiology and Molecular Genetics) at the University of California, Irvine.
1) Host-pathogen interactions: how this intracellular bacterium dysregulates the centrosome, cilia, endoplasmic reticulum, cell cycle, cytoskeleton and intracellular trafficking of the infected host cell.
2) Developmental regulation: how Chlamydia controls differentiation between its replicating and infectious forms with mechanisms such as its cell size, small RNAs and temporal gene expression.
Example of our work:
Experience in cellular microbiology, cell biology, confocal and super-resolution microscopy, genetics, and transcriptional and post-transcriptional regulation of gene expression would be advantageous.
To inquire, please contact Dr. Suetterlin (firstname.lastname@example.org) and Dr. Tan (email@example.com)
To apply, create an applicant profile at https://recruit.ap.uci.edu/JPF08079 and upload a current CV, Cover Letter, Statement of Research that includes a synopsis of previous research experience and specific interests in the ongoing work, Statement of Diversity Contributions, and contact information for 3 References.
Accepting All Applications.
Curriculum Vitae - Your most recently updated C.V.
Statement of Research
Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
Misc / Additional (Optional)
- 3-5 required (contact information only)
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a condition of employment, you will be required to comply with the University of California Policy on Vaccination Programs – With Updated Interim Amendments. All Covered Individuals under the policy must provide proof of receiving the COVID-19 Vaccine Primary Series or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, Religious Objection, and/or Deferral based on pregnancy or recent COVID-19 diagnosis and/or treatment) no later than the applicable deadline. All Covered Individuals must also provide proof of receiving the most recent CDC-recommended COVID-19 booster or properly decline such booster no later than the applicable deadline. New University of California employees should refer to Exhibit 2, Section II.C. of the SARS-CoV-2 (COVID-19) Vaccination Program Attachment for applicable deadlines. All Covered Individuals must also provide proof of being up-to-date on seasonal influenza vaccination or properly decline such vaccination no later than the applicable deadline. Please refer to the Seasonal Influenza Vaccination Program Attachment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.